Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Risk Factors Associated with Anticoagulant-Related Bleeding in Patients with Cancer-Associated Thrombosis

Alexa Loncharich, Suhong Lou, Brian F. Gage, Amber Afzal, Martin William Schoen, Kristen M. Sanfilippo

Blood (2023) 142 (Supplement 1): 5112.

https://doi.org/10.1182/blood-2023-191029

Published: 2023

Journal Articles

Survival Outcomes in Patients with Intermediate and High-Risk Pulmonary Embolism Treated with Low Molecular Weight or Unfractionated Heparin: Time to Start of Anticoagulant Therapy

Kelsey E. Bria, Brian F. Gage, Serena Flórez Marqués, Melissa Beasley, Kim Kramer, Maanasi Samant, Nathan Droz, Kristen M. Sanfilippo

Blood (2023) 142 (Supplement 1): 3744.

https://doi.org/10.1182/blood-2023-187789

Published: 2023

Journal Articles

Discriminating Risk of Anticoagulant-Related Bleeding in Ambulatory Cancer Patients on Thromboprophylaxis

Kristen M. Sanfilippo, Yan Yan, Marc Carrier, Brian F. Gage

Blood (2023) 142 (Supplement 1): 567.

https://doi.org/10.1182/blood-2023-190795

Published: 2023

Journal Articles

Monoclonal Gammopathy of Undetermined Significance and Risk of Cardiovascular Disease in US Veterans

Lawrence Liu, Niharika Pant, Mei Wang, Nikhil Grandhi, Ekaterina Proskuriakova, Murali Janakiram, Theodore Thomas, Kristen M. Sanfilippo, Graham Colditz, Daphne R Friedman, Martin William Schoen, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 4773.

https://doi.org/10.1182/blood-2023-185155

Published: 2023

Journal Articles

Clinical and Laboratory Indications for Serum Protein Electrophoresis Testing in US Veterans: A Retrospective Cohort Study

Niharika Pant, Lawrence Liu, Mei Wang, Nikhil Grandhi, Theodore Thomas, Kristen M. Sanfilippo, Graham Colditz, Daphne R Friedman, Martin William Schoen, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 4778.

https://doi.org/10.1182/blood-2023-190735

Published: 2023

Journal Articles

Monoclonal Protein Concentration and Risk of Multiple Myeloma: Is 0.5 g/DL the New 1.5?

Mahta Salehi, Mei Wang, Kristen M. Sanfilippo, Theodore Thomas, Martin William Schoen, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 2040.

https://doi.org/10.1182/blood-2023-190852

Published: 2023

Journal Articles

Racial Differences in the Association of Glucagon-like Peptide 1 Agonist Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in US Veterans with Diabetes Mellitus

Nikhil Grandhi, Lawrence Liu, Mei Wang, Theodore Thomas, Akhil Kumar, Feng Gao, Kristen M. Sanfilippo, Graham Colditz, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 4772.

https://doi.org/10.1182/blood-2023-179135

Published: 2023

Journal Articles

TPO-RAs and ITP remission: cause or coincidence?

Kristen M. Sanfilippo, Adam Cuker

Blood (2023) 141 (23): 2790–2791.

https://doi.org/10.1182/blood.2023020243

Published: 2023

Journal Articles

Association between SLGT2 Inhibitor Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Nikhil Grandhi, Lawrence Liu, Mei Wang, Theodore S. Thomas, Kristen M. Sanfilippo, Feng Gao, Graham A Colditz, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 10022–10023.

https://doi.org/10.1182/blood-2022-167846

Published: 2022

Journal Articles

Racial Difference in Dynamic Markers for Progression of MGUS Using Machine Learning Approaches

Yaochi Yu, Mei Wang, Lawrence Liu, Theodore S. Thomas, Martin Schoen, Kristen M. Sanfilippo, Graham A Colditz, Jr-Shin Li, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 7830–7831.

https://doi.org/10.1182/blood-2022-167464

Published: 2022

Journal Articles

Venous Thromboembolism Risk in Patients with Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination with Lenalidomide and Dexamethasone

Alexa J Loncharich, Mark A Fiala, Michael J Slade, Angela Vickroy, Margaret Kavanaugh, Kari Wilson, Mark A. Schroeder, Keith E Stockerl-Goldstein, Ravi Vij, Kristen M. Sanfilippo

Blood (2022) 140 (Supplement 1): 8550–8551.

https://doi.org/10.1182/blood-2022-166736

Published: 2022

Journal Articles

Available Risk Scores Modestly Predict Hemorrhage in Patients with Atrial Fibrillation and Cance

Kristen M. Sanfilippo, Suhong Luo, Martin W. Schoen, Su-Hsin Chang, Brian F. Gage

Blood (2022) 140 (Supplement 1): 8528–8529.

https://doi.org/10.1182/blood-2022-168223

Published: 2022

Journal Articles

The Association between Body Mass Index Trajectory and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Lawrence Liu, Nikhil Grandhi, Mei Wang, Theodore S. Thomas, Akhil Kumar, Kristin Vargo, Kristen M. Sanfilippo, Graham A Colditz, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 4283–4284.

https://doi.org/10.1182/blood-2022-167126

Published: 2022

Journal Articles

Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer

Kristen M. Sanfilippo, Suhong Luo, Gary H. Lyman, David C. Calverley, Dr. Nicole M.M. Kuderer

Blood (2022) 140 (Supplement 1): 2803–2804.

https://doi.org/10.1182/blood-2022-165748

Published: 2022

Journal Articles

The Association of Agent Orange Exposure Duration with Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma Progression: A Population-Based Study

Lawrence Liu, Mei Wang, Nikhil Grandhi, Mark A. Schroeder, Theodore S. Thomas, Akhil Kumar, Kristin Vargo, Feng Gao, Kristen M. Sanfilippo, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 4356–4357.

https://doi.org/10.1182/blood-2022-167305

Published: 2022

Journal Articles

Complementing venous thromboembolism, a risky move

Kristen M. Sanfilippo

Blood (2021) 138 (21): 2018–2019.

https://doi.org/10.1182/blood.2021013267

Published: 2021

Journal Articles

Bleeding Outcomes in Patients with Gastrointestinal Malignancies Treated with Distally Absorbed Versus Proximally Absorbed Direct Oral Anticoagulants

Kristen M. Sanfilippo, Suhong Luo, Tzu-Fei Wang

Blood (2021) 138 (Supplement 1): 3027.

https://doi.org/10.1182/blood-2021-154311

Published: 2021

Journal Articles

D-Dimer Improves Risk Prediction of Venous Thromboembolism in Patients with Multiple Myeloma

Kristen M. Sanfilippo, MD MPHS, Mark A Fiala, MSW, Harsha Tathireddy, MD, Dan Feinberg, Ravi Vij, MD MBA, Brian F. Gage, MD MSc

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142762

Published: 2020

Journal Articles

Elevated International Normalized Ratio (INR) Did Not Prevent Against Thrombosis in Patients with Chronic Liver Disease (CLD): A Population Based Study

Amber Afzal, MD, Brian F. Gage, MD MSc, Suhong Luo, MPH, Martin W. Schoen, MDMPH, Kristen M. Sanfilippo, MD MPHS

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-142689

Published: 2020

Journal Articles

Outcomes in Multiple Myeloma Based on Comorbidities and Race

Martin W. Schoen, MDMPH, Kenneth R. Carson, MD PhD, Suhong Luo, MPH, Kristen M. Sanfilippo, MD MPHS

Blood (2019) 134 (Supplement_1): 383.

https://doi.org/10.1182/blood-2019-121807

Published: 2019

NARROW

Risk Factors Associated with Anticoagulant-Related Bleeding in Patients with Cancer-Associated Thrombosis

Survival Outcomes in Patients with Intermediate and High-Risk Pulmonary Embolism Treated with Low Molecular Weight or Unfractionated Heparin: Time to Start of Anticoagulant Therapy

Discriminating Risk of Anticoagulant-Related Bleeding in Ambulatory Cancer Patients on Thromboprophylaxis

Monoclonal Gammopathy of Undetermined Significance and Risk of Cardiovascular Disease in US Veterans

Clinical and Laboratory Indications for Serum Protein Electrophoresis Testing in US Veterans: A Retrospective Cohort Study

Monoclonal Protein Concentration and Risk of Multiple Myeloma: Is 0.5 g/DL the New 1.5?

Racial Differences in the Association of Glucagon-like Peptide 1 Agonist Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in US Veterans with Diabetes Mellitus

TPO-RAs and ITP remission: cause or coincidence?

Association between SLGT2 Inhibitor Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Racial Difference in Dynamic Markers for Progression of MGUS Using Machine Learning Approaches

Venous Thromboembolism Risk in Patients with Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination with Lenalidomide and Dexamethasone

Available Risk Scores Modestly Predict Hemorrhage in Patients with Atrial Fibrillation and Cance

The Association between Body Mass Index Trajectory and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer

The Association of Agent Orange Exposure Duration with Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma Progression: A Population-Based Study

Complementing venous thromboembolism, a risky move

Bleeding Outcomes in Patients with Gastrointestinal Malignancies Treated with Distally Absorbed Versus Proximally Absorbed Direct Oral Anticoagulants

D-Dimer Improves Risk Prediction of Venous Thromboembolism in Patients with Multiple Myeloma

Elevated International Normalized Ratio (INR) Did Not Prevent Against Thrombosis in Patients with Chronic Liver Disease (CLD): A Population Based Study

Outcomes in Multiple Myeloma Based on Comorbidities and Race

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only